Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancer treatment and research"
DOI: 10.1007/978-3-030-78311-2_4
Abstract: Acute myeloid leukemia (AML) is predominantly a disease of older adults and the majority of affected patients succumb to the disease. After decades of slow progress, the last 5 years have witnessed remarkable progress in AML…
read more here.
Keywords:
myeloid leukemia;
current emerging;
acute myeloid;
emerging therapies ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Targeted Oncology"
DOI: 10.1007/s11523-017-0503-8
Abstract: Acute myeloid leukemia (AML) is one of the best studied malignancies, and significant progress has been made in understanding the clinical implications of its disease biology. Unfortunately, drug development has not kept pace, as the…
read more here.
Keywords:
myeloid leukemia;
acute myeloid;
therapy;
therapies acute ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Interventional cardiology clinics"
DOI: 10.1016/j.iccl.2019.12.003
Abstract: Treatment of acute pulmonary embolism (PE) historically included anticoagulation and systemic thrombolytic therapy. More recently, catheter guided interventions provided promise of mitigating bleeding risks usually associated with systemic thrombolysis in intermediate to high risk PE…
read more here.
Keywords:
therapies acute;
pulmonary embolism;
cardiology;
interventional therapies ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2017.1366852
Abstract: ABSTRACT Introduction: Acute myeloid leukemia (AML) remains a therapeutic challenge. Despite ongoing research, the standard therapy for AML has not changed significantly in the past four decades. With the identification of cytogenetic and molecular abnormalities,…
read more here.
Keywords:
myeloid leukemia;
acute myeloid;
therapies acute;
aml ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "F1000Research"
DOI: 10.12688/f1000research.21100.1
Abstract: Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time…
read more here.
Keywords:
ischemic stroke;
acute ischemic;
emerging therapies;
therapies acute ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s121477
Abstract: Vosaroxin, a quinolone-derivative chemotherapeutic agent, was considered a promising drug for the treatment of acute myeloid leukemia (AML). Early-stage clinical trials with this agent led to a large randomized double-blind placebo-controlled study of vosaroxin in…
read more here.
Keywords:
myeloid leukemia;
vosaroxin;
acute myeloid;
therapies acute ... See more keywords